Lucira Health, Inc. (LHDX) Social Stream



Lucira Health, Inc. (LHDX): $1.86

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Lucira Health Inc (LHDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LHDX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-19 3 $5.5 $5.5 $5.5 $3.62 51.93%
2021-11-11 3 $6.5 $6.5 $6.5 $3.62 79.56%
2021-11-12 3 $9 $6.5 $7.75 $3.62 114.09%
2022-03-11 3 $9 $7 $8 $3.62 120.99%
2022-03-22 3 $7 $7 $7 $3.62 93.37%

The Trend in the Analyst Price Target


Over the past 26 weeks, LHDX's average price target has gone down $1.5.

Over the past 48 weeks, LHDX's average upside potential has been 46.67%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 3 29 9 19.0 6.93 174.17%
2021-07-24 3 9 8 8.5 7.98 6.52%
2021-08-28 3 9 8 8.5 9.57 -11.18%
2021-09-04 3 9 8 8.5 8.92 -4.71%
2021-09-09 3 9 8 8.5 8.54 -0.47%

LHDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 1 0 1 0 0 3

The Trend in the Broker Recommendations


LHDX's average broker recommendation rating improved by 0.66 over the prior 28 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LHDX as an investment opportunity.

  • Lucira Health Inc's average analyst price target is higher than 25.66% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Lucira Health Inc's variance in analysts' estimates is lower than 55.2% of them.
  • LHDX has a higher number of analysts covering the stock than 62.75% of Healthcare stocks.
  • Lucira Health Inc's upside potential (average analyst target price relative to current price) is higher than 163.57% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, AWH, ACHV, and ABIO are the three stocks most similar to Lucira Health Inc regarding the price target and analyst recommendation information presented here.

Is LHDX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3664 seconds.